University of Virginia Health System
Skip Navigation
Health System
Calendars
Maps
A-Z Index
UVa
HS Web
People
Pediatrics
Clinical Facilities
For Patients & Families
For Healthcare Professionals
Residency Program
Fellowship Information
Pharmacology Newsletter
Tutorials for Children & Familes
Volunteer
Make a Gift
Pediatric Intranet (for faculty and staff)
Search this Site
Keywords or Phrases
View the Site Index
Adolescent Medicine
Allergy/Asthma/Immunology
Arthritis & Rheumatology
Blood Disorders
Burns
Cancer
Common Injuries/Poison Tips
Craniofacial Anomalies
Dermatology
Diabetes/Endo/Metabolism
Digestive & Liver Disorders
Ear, Nose & Throat
Eye Care
Genitourinary/Kidney
Growth & Development
Heart & Vascular Disorders
High-Risk Newborn
High-Risk Pregnancy
Infectious Diseases
Medical Genetics
Mental Health
Nervous System Disorders
Normal Newborns
Oral Health
Orthopaedics
Pediatric Surgery
Pregnancy & Childbirth
Respiratory Disorders
Safety & Injury Prevention
Terminal Illness in Children
Transplantation
Interacting Neurotransmitters
Tyrosine Hydroxylase is the rate limiting step in Dopamine synthesis. Since norepinephrine and epinephrine inhibit tyrosine hydroxylase, pharmacologically modulating one neurotransmitter may affect levels of other neurotransmitters.
Use
BACK BUTTON
to return to previous page.
